This randomized controlled trial aimed to examine the effectiveness of a 10-session acceptance-based, insight-inducing medication adherence therapy (AIM-AT) program for recent-onset psychosis (in addition to usual care) over a 12-month follow-up (i.e., at immediate, 6-month, and 12-month post-intervention).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Adherence Rating Scale
Timeframe: Baseline (At recruitment)
Adherence Rating Scale
Timeframe: At immediate (1-2 weeks) post-intervention
Adherence Rating Scale
Timeframe: At 6 months post-intervention
Adherence Rating Scale
Timeframe: At 12 months post-intervention
Insight and Treatment Attitude Questionnaire (ITAQ)
Timeframe: At immediate (1-2 weeks) post-intervention
Insight and Treatment Attitude Questionnaire (ITAQ)
Timeframe: At 6 months post-intervention
Insight and Treatment Attitude Questionnaire (ITAQ)
Timeframe: At 12 months post-intervention